July 07, 2015 – Carlsbad, CA and Munich, Germany
The twenty-first annual BIO-Europe® international life science partnering conference will be held in Munich, Germany, November 2–4, 2015. Organized by EBD Group, the event is co-hosted by BioM Biotech Cluster Development, the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, and Cluster Biotechnology Bavaria.
Bavaria is an ideal location because it is home to a broad spectrum of high-capacity industries including life sciences and is a leading business region in Europe. There are 270 life science companies in the Munich biotech cluster, characterized by innovative small and medium-sized biotech companies and a focus on new therapeutics and diagnostics, “omics”-technologies, personalized medicine and biomarker research.
“Collaboration is the key to success in today’s rapidly changing drug development culture,” said Horst Domdey, Managing Director of BioM Biotech Cluster Development GmbH, the main office for biotechnology in Bavaria. “We welcome BIO-Europe to Munich, the hotspot for biopharmaceutical innovation in Europe. We are keen to showcase again to key international life science leadership what our legendary hospitality means in combination with our age-old motto: innovation by tradition..”
BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry and is facilitated by EBD Group’s partneringONE®, the gold standard one-to-one networking solution for the life sciences.
“We are pleased to return to Munich this year as it is an extremely active life science cluster with a rich history and tradition in biotechnology research and innovation,” said Anna Chrisman, Group Managing Director, EBD Group.
A highlight of the event are the company presentations by early stage projects, innovative startups, established biotechs and midsize pharma companies. The deadline to submit an application to present is July 31, 2015. Apply now.
International pharma companies already confirmed to attend include AbbVie, Almirall, Amgen, AstraZeneca, Baxalta, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, GSK, Johnson Johnson, Lilly, Merck Serono, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shire, and Takeda.
The 2014 edition featured 17,902 one-to-one partnering meetings. Over 3,200 delegates from 1,772 companies representing 54 countries attended. There were 162 company presentations with 4,032 licensing opportunities on offer, and 98 exhibitors at the event.
Editor’s Details
Mike Wood
PharmiWeb.com
http://www.pharmiweb.com
editor@pharmiweb.com
Last updated on: 09/07/2015